Health & Biotech
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
News
ScoPo’s Powerplays: Mental health takes centre stage; Actinogen to progress Alzheimer’s study
Health & Biotech
MGC Pharma to commence three vital clinical trials in 2021
Health & Biotech
These ASX biotechs are on the verge of releasing Phase III clinical trial results
Health & Biotech
MGC Pharma ready to march ahead with three clinical trials in 2021
Health & Biotech
MGC Pharma submits patent for COVID-19 inflammation drug CimetrA, ahead of Phase III trials
Health & Biotech
Confusion and selloff as Credit Suisse pulls plug on US cannabis stocks
Health & Biotech
MGC Pharma announces exciting new developments in the fight against COVID-19
Health & Biotech
MGC Pharma builds on momentum with a new $1 million order
Health & Biotech
MGC’s COVID-19 treatment spray takes big step forward in North America
Health & Biotech
MGC Pharma acquires clinical trials research company MediCaNL
News
ASX Small Cap Lunch Wrap: Today’s high flyers and sinking ships
Health & Biotech
MGC Pharma delivers first batch order to Swiss PharmaCan, notches record sales quarter
Health & Biotech
MGC Pharmaceuticals receives go-ahead for Phase III trial of COVID-19 treatment
Health & Biotech
Huge shakeup expected as British American Tobacco makes a move on Canadian cannabis
Health & Biotech
Normal service is resuming for pot stocks as WSB buzz dies down
Health & Biotech
This cannabis ETF is still enjoying the wallstreetbets treatment
News